Solid biosciences added to the nasdaq biotechnology index

Charlestown, mass., dec. 23, 2024 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company” or “solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it was added to the nasdaq biotechnology index® (nasdaq: nbi) effective prior to the market open on monday, december 23, 2024.

SLDB Ratings Summary

SLDB Quant Ranking